While some reports have evidenced the benefits of COX-2 inhibitors, other reports show that during AKI, the imbalance of fluid secretion and intra-renal hemodynamic inhibits COX-2, accounting for impairment in the renal function (79). This evidence concerns the gene PTGS2 and acute kidney injury.